Table 3 Comparison of AF awareness, medication utilization, symptoms and risk factors before and after management in 243 NVAF patients
Characteristics | Baseline | 6 months | 1 year | P value |
|---|---|---|---|---|
Education, n(%) | ||||
Awareness of AF, n(%) | 68(28.0) | 178(73.3) | 233(95.9) | <0.001 |
Awareness of AF hazards, n(%) | 44(18.1) | 177(72.8) | 218(89.7) | <0.001 |
Atrial fibrillation treatment, n(%) | ||||
Use of anticoagulants | 29(11.9) | 66(27.1) | 122(50.3) | <0.001 |
Types of anticoagulants | ||||
 Warfarin | 16(6.6) | 21(8.6) | 22(9.1) | 0.565 |
 NOACs | 13(5.3) | 45(18.5) | 100(41.2) | <0.001 |
Use of antiplatelets | 17(7.0) | 18(7.4) | 15(6.2) | 0.860 |
Use of heart rate control drugs | 65(26.7) | 96(39.5) | 114(46.9) | <0.001 |
Compliance of symptoms and risk factors, n(%) | ||||
Heart rate reaches target | 191(78.6) | 199(81.9) | 203(83.5) | 0.363 |
Blood pressure reaches target | 72(29.6) | 92(37.9) | 105(43.2) | 0.008 |
Blood glucose reaches target | 196(80.7) | 209(86.0) | 215(88.5) | 0.047 |
BMI reaches target | 76(31.3) | 92(37.9) | 102(42.0) | 0.048 |
Adverse events within follow-up, n(%) | ||||
New thromboembolic events | 0(0.0) | / | 4(1.6) | 0.045 |
 With anticoagulants | 0(0.0) | / | 0(0.0) | / |
New bleeding events | 0(0.0) | / | 3(1.2) | 0.082 |
 With anticoagulants | 0(0.0) | / | 1(0.8) | 0.625 |